Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.93% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NKTR · Jun 30, 2026
NEKTAR THERAPEUTICS. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-349805General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-747.90% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-9.34% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-417.94% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
386.23% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
33.21% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.17%
- Current
- 0.93%
- Delta
- 0.76%
- Previous
- -407.86%
- Current
- -747.90%
- Delta
- -340.04%
- Previous
- 3.83%
- Current
- -9.34%
- Delta
- -13.18%
- Previous
- -359.58%
- Current
- -417.94%
- Delta
- -58.35%
- Previous
- 328.51%
- Current
- 386.23%
- Delta
- 57.72%
- Previous
- 30.89%
- Current
- 33.21%
- Delta
- 2.32%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Derived From · NKTR Company Quality Vector →Has State · NEKTAR THERAPEUTICS →Transitioned To · NKTR Fundamental State →Transitioned To · NKTR CAPEX_INTENSITY_INCREASED →Transitioned To · NKTR CASH_GENERATION_DECREASED →Transitioned To · NKTR GROWTH_DECREASED →Transitioned To · NKTR PROFITABILITY_DECREASED →Transitioned To · NKTR R_AND_D_INTENSITY_INCREASED →Transitioned To · NKTR SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.